This website uses cookies and similar technologies to deliver its services, to analyse and improve performance and to provide personalised content and advertising. Information about your use of this website will be shared with Google and other third parties. Read our privacy policy.

Gene and cell therapy concept image
Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, manufactured for each individual patient using their own T cells
Adeno-associated virus serotype 1
Researcher working in the Cell and Gene Therapy Catapult manufacturing centre
The Cell and Gene Therapy Catapult
Oxford BioMedica building